Caprock Group LLC Makes New $1.66 Million Investment in GE HealthCare Technologies Inc. $GEHC

Caprock Group LLC bought a new stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 22,565 shares of the company’s stock, valued at approximately $1,664,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Empowered Funds LLC raised its position in shares of GE HealthCare Technologies by 6.1% during the first quarter. Empowered Funds LLC now owns 28,848 shares of the company’s stock worth $2,328,000 after acquiring an additional 1,665 shares during the last quarter. Acadian Asset Management LLC bought a new position in GE HealthCare Technologies during the 1st quarter worth approximately $259,000. Aberdeen Group plc lifted its position in shares of GE HealthCare Technologies by 7.5% in the 2nd quarter. Aberdeen Group plc now owns 112,065 shares of the company’s stock worth $8,301,000 after purchasing an additional 7,791 shares during the period. Concurrent Investment Advisors LLC boosted its stake in shares of GE HealthCare Technologies by 31.6% in the 2nd quarter. Concurrent Investment Advisors LLC now owns 8,529 shares of the company’s stock valued at $632,000 after purchasing an additional 2,049 shares during the last quarter. Finally, Sequoia Financial Advisors LLC increased its position in shares of GE HealthCare Technologies by 20.9% during the second quarter. Sequoia Financial Advisors LLC now owns 18,297 shares of the company’s stock worth $1,355,000 after buying an additional 3,166 shares during the period. Institutional investors own 82.06% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on GEHC shares. Evercore boosted their target price on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company an “outperform” rating in a report on Thursday, February 5th. Jefferies Financial Group boosted their price objective on GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a research note on Thursday, December 11th. The Goldman Sachs Group restated a “buy” rating and set a $98.00 target price on shares of GE HealthCare Technologies in a research report on Friday, January 9th. Morgan Stanley lifted their target price on GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a report on Wednesday, February 4th. Finally, Barclays boosted their price target on GE HealthCare Technologies from $86.00 to $87.00 and gave the company an “equal weight” rating in a research note on Friday, February 6th. Seven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $92.50.

GE HealthCare Technologies Stock Up 2.1%

GE HealthCare Technologies stock opened at $80.34 on Friday. The firm has a market capitalization of $36.61 billion, a price-to-earnings ratio of 17.62, a price-to-earnings-growth ratio of 1.73 and a beta of 1.08. The firm’s fifty day moving average price is $82.44 and its two-hundred day moving average price is $77.62. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $93.26. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. The company had revenue of $5.70 billion for the quarter, compared to analyst estimates of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The firm’s revenue was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, equities research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be issued a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies’s payout ratio is currently 3.07%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.